Adamant Health
Lauri Lehtovaara is a seasoned professional with extensive experience in AI architecture, executive leadership, and scientific research. Currently serving as a Senior AI Architect at Adamant Health and Chief Executive Officer of Prime Authentication Solutions Finland Oy, Lauri also co-founded Onerva Hoivaviestintä Oy, focusing on enhancing communication in elderly care. As the founder and CEO of Lapio Mindcraft Oy, Lauri operates an idea incubator and testbed. Previous roles include Machine Learning Engineer at Recordly and Data Engineer at Silo.AI, with a strong academic foundation as an Academy Research Fellow at the University of Jyväskylä and post-doctoral positions at prominent institutions. Lauri holds both an MSc and PhD in Physical Chemistry from the University of Jyväskylä.
This person is not in any teams
This person is not in any offices
Adamant Health
We are helping people with Parkinson's disease by providing an accurate and clear picture of their condition to get the best treatment possible, improving their quality of life. Adamant Health is a Finnish health-tech startup on a mission to revolutionize the care of Parkinson’s disease by enabling data-driven disease management, supporting earlier diagnosis and improving patient outcomes. The company was founded in 2020 as a spin-off from the University of Eastern Finland to bring our research-based, innovative technology to patients, clinicians, healthcare service providers and companies developing new therapies. We have developed the first, advanced precision technology able to measure the visible and invisible motor symptoms of Parkinson's disease. Our unique CE-marked data-analysis technology, based on surface electromyography (EMG) and motion measurement, provides detailed and accurate symptom data, essential for supporting personalized treatment that can be continuously optimized. Our technology is based on over 15 years of research with more than 25 scientific articles published in international publications. In addition to Parkinson's disease, our technology brings also visibility to the symptoms of various other movement disorders.